Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 14:2024:4937501.
doi: 10.1155/2024/4937501. eCollection 2024.

Recurrent Inflammatory Myofibroblastic Tumor of Larynx Harboring a Novel THBS1::ALK Fusion

Affiliations
Review

Recurrent Inflammatory Myofibroblastic Tumor of Larynx Harboring a Novel THBS1::ALK Fusion

Namra Ajmal et al. Int J Genomics. .

Abstract

Inflammatory myofibroblastic tumor (IMT) is a rare soft tissue tumor primarily occurring in the abdominopelvic region of young patients, and it is characterized by spindle-shaped myofibroblasts, or fibroblasts surrounded by inflammatory infiltrate. Herein, we report a case of a 24-year-old male with a firm submucosal mass in the anterior right vocal fold diagnosed as an IMT that recurred 14 months later. The tumor demonstrated a novel THBS1::ALK fusion containing Exons 1-7 of the thrombospondin 1 (THBS1) gene fused to Exon 19 of the anaplastic lymphoma kinase (ALK) gene via next-generation sequencing with the NextSeq sequencer. The fusion of THBS1 to ALK potentially results in increased expression and constitutive activation of the ALK kinase domain. These findings not only broaden the repertoire of known ALK fusion partners implicated in tumorigenesis but also provide a novel avenue for investigating the etiology of recurrent IMT by considering this fusion event as a causal factor. To our knowledge, this is the second case of IMT of the larynx with this novel mutation reported in the literature and the first such case with a detailed description of this specific fusion and clinical recurrence.

Keywords: ALK fusion; IMT; Inflammatory myofibroblastic tumor; THBS1; larynx.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Timeline of events from initial presentation to present.
Figure 2
Figure 2
(a) Section showing benign squamous mucosa with rare inflammatory cells. Beneath squamous mucosa, fascicles of spindle cells are present (haematoxylin and eosin stain, magnification ×200). (b) Microscopic sections show a dense spindle cell proliferation associated with acute inflammatory (arrow) and lymphoplasmacytic infiltrate (haematoxylin and eosin stain ×400). (c) The spindle cells show diffuse cytoplasmic granular staining for anaplastic lymphoma kinase-1 (ALK1), (immunohistochemistry staining ×400). (d) The spindle cells show focal staining for alpha-smooth muscle actin (SMA) (immunohistochemistry staining ×400).
Figure 3
Figure 3
(a) G-banding ideograms of Chromosomes 2 and 15. The location of the THBS1 and ALK genes on respective chromosomes. Molecular characterization of FFPE sample from the larynx, right vocal fold mass. (b) NGS revealed an in-frame novel THBS1-ALK fusion with 5′ partner (Exons 1–7) of THBS1 and 3′ (Exons 19–29) of ALK. VWC, von Willebrand factor type C domain (318-372); TSP_1, thrombospondin Type 1 domain (383-428); EGF, calcium-binding EGF domain (588-625); TSP_3, thrombospondin Type 3 repeat (727-762); TSP_C, thrombospondin C-terminal region (972-1169); MAM-MAM domain, meprin/A5/mu (285-426); Gly_rich, glycine rich protein (733-960); Pkinase_Tyr, protein tyrosine kinase (1117-1382).

Similar articles

Cited by

References

    1. Colizza A., Meliante P. G., Donsante S., et al. Inflammatory myofibroblastic tumour of the larynx: report of a case. Ear, Nose, & Throat Journal . 2022;9, article 1455613221101087 doi: 10.1177/01455613221101087. - DOI - PubMed
    1. Hornick J. L., Yamamoto H. WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours . Vol. 3. Lyon, France: International Agency for Research on Cancer; 2020. Inflammatory myofibroblastic tumour. (WHO classification of tumours series, 5th ed). https://tumourclassification.iarc.who.int/chapters/33 .
    1. Casanova M., Brennan B., Alaggio R., et al. Inflammatory myofibroblastic tumor: the experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG) European Journal of Cancer . 2020;127:123–129. doi: 10.1016/j.ejca.2019.12.021. - DOI - PubMed
    1. Wenig B. M., Devaney K., Bisceglia M. Inflammatory myofibroblastic tumor of the larynx. A clinicopathologic study of eight cases simulating a malignant spindle cell neoplasm. Cancer . 1995;76(11):2217–2229. doi: 10.1002/1097-0142(19951201)76:11<2217::aid-cncr2820761107>3.0.co;2-n. - DOI - PubMed
    1. Cantera J. E., Alfaro M. P., Rafart D. C., et al. Inflammatory myofibroblastic tumours: a pictorial review. Insights into Imaging . 2015;6(1):85–96. doi: 10.1007/s13244-014-0370-0. - DOI - PMC - PubMed

LinkOut - more resources